Medicover AB (publ) (MCOV_B) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the MediCover Q3 2025 report presentation. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers. CEO John Stubbington and CFO Anand Patel, please go ahead. Morning, everybody. John here. Welcome to our Q3 report. And I'd like to start with thanking all of our people for producing a really good result. So thank you for all your hard work. Q1, I described as strong. Q2, I described as stronger. I think Q3, you know, what we're seeing here is a really good, solid, consistent and healthy performance. If you look on the right hand side, you can see growth is a good performance at 12.1%, especially when you consider that Hungary no longer is in these numbers. So that's quite a pleasing position for us. If you look at a bit, it's a very respectable increase of 32% which is really positive for us and you can see that coming through with the adjusted margin of 17.2. Moving up by 14.6 is really, really solid and quite an impressive performance by the team. We'll talk about that a little bit later on because there's Some other sort of factors that are pushing that forward and pushing that back. And we'll try and give you a bit more context on that. Operating cash flows, again, very healthy, 98.8. A positive movement of 36.7, which is, again, really pleasing for us and good to see is what we need. So that's really, really good. And as predicted, we talked about our leverage that as we did the acquisitions that that would come down, and we see that that is coming down despite the fact that we did our two biggest deals ever in Q2, which has been very posi...